University Hospital Oslo

Oslo 0379

1 studies enrolling now · 2 studies all time

What they study most

Cholangiocarcinoma, Hepatocellular Carcinoma (HCC), NRG1 Fusion, NSCLC Harboring NRG1 Fusion, Pancreatic Cancer Harboring NRG1 Fusion, Primary Liver Cancer, Solid Tumours Harboring NRG1 Fusion

Studies at this site

• The Dragon PLC Trial (DRAGON-PLC) — Recruiting now
• A Study of Zenocutuzumab (MCLA-128) in Patients With Solid Tumors Harboring an NRG1 Fusion (eNRGy) — Running, not enrolling